Related Experiment Video
Updated: Aug 11, 2026

Visualization of DNA Repair Proteins Interaction by Immunofluorescence
Published on: June 26, 2020
14-3-3gamma binds to MDMX that is phosphorylated by UV-activated Chk1, resulting in p53 activation
Yetao Jin1, Mu-Shui Dai, Steven Z Lu
1Department of Biochemistry and Molecular Biology, Oregon Health and Science University, Portland, OR 97239, USA.
Abstract:
It has been shown that MDMX inhibits the activity of the tumor suppressor p53 by primarily cooperating with the p53 feedback regulator MDM2. Here, our study shows that this inhibition can be overcome by 14-3-3gamma and Chk1. 14-3-3gamma was identified as an MDMX-associated protein via an immuno-affinity purification-coupled mass spectrometry. Consistently, 14-3-3gamma directly interacted with MDMX in vitro, and this interaction was stimulated by MDMX phosphorylation in vitro and in cells. Interestingly, in response to UV irradiation, the wild-type, but not the kinase-dead mutant, Chk1 phosphorylated MDMX at serine 367, enhanced the 14-3-3gamma-MDMX binding and the cytoplasmic retaining of MDMX. The Chk1 specific inhibitor UCN-01 repressed all of these effects. Moreover, overexpression of 14-3-3gamma, but not its mutant K50E, which did not bind to MDMX, suppressed MDMX-enhanced p53 ubiquitination, leading to p53 stabilization and activation. Finally, ablation of 14-3-3gamma by siRNA reduced UV-induced p53 level and G1 arrest. Thus, these results demonstrate 14-3-3gamma and Chk1 as two novel regulators of MDMX in response to UV irradiation.
Insights
14-3-3gamma and Chk1 overcome MDMX inhibition of tumor suppressor p53. This study identifies these proteins as novel regulators of MDMX activity, particularly in response to UV irradiation, impacting p53 levels and cell cycle arrest.
Area of Science:
- Molecular Biology
- Cell Biology
- Oncology
Background:
- MDMX (also known as MDM4) inhibits the tumor suppressor p53, often in conjunction with MDM2.
- Understanding regulators of MDMX is crucial for developing cancer therapies targeting the p53 pathway.
Purpose of the Study:
- To identify novel proteins that regulate MDMX activity.
- To investigate the role of 14-3-3gamma and Chk1 in modulating the MDMX-p53 interaction.
- To elucidate the mechanism by which MDMX inhibition of p53 can be overcome.
Main Methods:
- Immuno-affinity purification coupled with mass spectrometry to identify MDMX-associated proteins.
- In vitro and in-cell binding assays to confirm protein interactions.
- Site-directed mutagenesis and kinase assays to study phosphorylation events.
- UV irradiation, siRNA-mediated gene silencing, and Western blotting to assess protein levels and cellular responses.
- Overexpression studies of wild-type and mutant proteins.
Main Results:
- 14-3-3gamma was identified as an MDMX-binding protein, with interaction enhanced by MDMX phosphorylation.
- Chk1 phosphorylates MDMX at serine 367 in response to UV irradiation, promoting 14-3-3gamma binding and MDMX cytoplasmic retention.
- Overexpression of 14-3-3gamma suppressed MDMX-mediated p53 ubiquitination, leading to p53 stabilization and activation.
- Ablation of 14-3-3gamma reduced UV-induced p53 levels and G1 cell cycle arrest.
Conclusions:
- 14-3-3gamma and Chk1 are novel regulators of MDMX.
- These proteins counteract MDMX-mediated inhibition of p53, particularly under UV stress.
- The findings reveal a new mechanism for controlling p53 activity via MDMX modulation.
Related Concept Videos
Abnormal Proliferation
DNA Damage Can Stall the Cell Cycle
DNA Damage can Stall the Cell Cycle
Negative Regulator Molecules
M-Cdk Drives Transition Into Mitosis
Cyclin-dependent kinases, or Cdks, work in concert with cyclins to control cell cycle transitions. M-Cdk, a complex of Cdk1 bound to M cyclin, is a well-known example of this coordinated control that drives the transition from the G2 to the M phase.
M cyclin...
MAPK Signaling Cascades

